Literature DB >> 34057744

Molecular allergology and its impact in specific allergy diagnosis and therapy.

Domingo Barber1,2, Araceli Diaz-Perales2,3, Maria M Escribese1,2, Jörg Kleine-Tebbe4, Paolo M Matricardi5, Markus Ollert6,7, Alexandra F Santos8,9,10,11, Joaquin Sastre12.   

Abstract

Progressive knowledge of allergenic structures resulted in a broad availability of allergenic molecules for diagnosis. Component-resolved diagnosis allowed a better understanding of patient sensitization patterns, facilitating allergen immunotherapy decisions. In parallel to the discovery of allergenic molecules, there was a progressive development of a regulation framework that affected both in vitro diagnostics and Allergen Immunotherapy products. With a progressive understanding of underlying mechanisms associated to Allergen immunotherapy and an increasing experience of application of molecular diagnosis in daily life, we focus in analyzing the evidences of the value provided by molecular allergology in daily clinical practice, with a focus on Allergen Immunotherapy decisions.
© 2021 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.

Entities:  

Keywords:  allergen immunotherapy; component-resolved diagnosis; food allergy; major allergen; respiratory allergy

Mesh:

Substances:

Year:  2021        PMID: 34057744     DOI: 10.1111/all.14969

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  2 in total

Review 1.  Asthma and Allergy: Unravelling a Tangled Relationship with a Focus on New Biomarkers and Treatment.

Authors:  Pablo Rodriguez Del Rio; Andrew H Liu; Magnus P Borres; Eva Södergren; Fabio Iachetti; Thomas B Casale
Journal:  Int J Mol Sci       Date:  2022-03-31       Impact factor: 5.923

2.  Suitability of potyviral recombinant virus-like particles bearing a complete food allergen for immunotherapy vaccines.

Authors:  Diego Pazos-Castro; Clémence Margain; Zulema Gonzalez-Klein; Carmen Yuste-Calvo; Maria Garrido-Arandia; Lucía Zurita; Vanesa Esteban; Jaime Tome-Amat; Araceli Diaz-Perales; Fernando Ponz
Journal:  Front Immunol       Date:  2022-09-08       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.